| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/18/1987 | CA1225594A1 Method for percutaneously administering physiologically active agents |
| 08/18/1987 | CA1225585A1 Composition for embolization of blood vessels |
| 08/13/1987 | WO1987004711A1 Process for producing egg yolk lecithin containing a reduced amount of pe and/or containing substantially no impurities |
| 08/13/1987 | WO1987004706A1 Compositions comprising 1-substituted azacycloalkanes and their uses |
| 08/13/1987 | WO1987004622A1 Amino acid chelated compositions for delivery to specific biological tissue sites |
| 08/13/1987 | WO1987004617A1 Pharmaceutical compositions containing propylene glycol and/or polyethylene glycol and urea as active main components and use thereof |
| 08/13/1987 | WO1987004599A1 Flour, bread, milk, and other products from white sweet potatoes, cassava, edible aroids, amaranth, yams, and lotus |
| 08/13/1987 | WO1987004594A1 Compositions comprising 1-substituted azacycloalkanes and their uses |
| 08/13/1987 | WO1987004593A1 Compositions comprising 1-substituted azacycloalkanes and their uses |
| 08/12/1987 | EP0232155A2 Drug delivery system |
| 08/12/1987 | EP0231816A2 Pharmaceutical preparations for the stabilization of interferon alpha |
| 08/12/1987 | EP0231649A1 Albumin complex |
| 08/12/1987 | EP0231643A1 Dehydration of hydrous matter using anhydrous lactitol |
| 08/11/1987 | US4686212 Stable sodium aspirin tablet compositions |
| 08/11/1987 | US4686211 Medical composition for external application |
| 08/11/1987 | US4685911 Patch |
| 08/05/1987 | EP0231040A1 Pharmaceutical preparation for obtaining a highly viscous hydrogel or suspension |
| 08/05/1987 | EP0231039A1 Process for preparing immunological complexes and pharmaceutical composition containing these complexes |
| 08/05/1987 | EP0231026A1 Sustained-release dihydropyridine formulation |
| 08/05/1987 | EP0230881A2 Pharmaceutical preparations containing ciprofloxacin |
| 08/05/1987 | EP0179092A4 Solutions of mitomycin. |
| 08/04/1987 | US4684728 Solubilizing biologically active compounds with reactive hydrogen atoms |
| 08/04/1987 | US4684666 Ibuprofen syrup |
| 08/04/1987 | US4684638 Metal complexes of bis-indole compounds and aqueous pharmaceutical compositions containing them |
| 08/04/1987 | US4684632 Formulation with special 1,2-diacylglycero-3-phosphocholines for the treatment of gastrointestinal disorders |
| 08/04/1987 | US4684630 Water unstable azacytidine and 5-azacytosine arabinose in an aqueous diluted dmso and dimethylacetamide solution |
| 08/04/1987 | CA1225032A1 Injectable therapeutic compositions containing stable s-adenosyl-l-methionine salts |
| 08/04/1987 | CA1225030A1 Crosslinked, porous polymers for controlled drug delivery |
| 08/04/1987 | CA1225029A1 Medicaments with a high degree of solubility and method for their production |
| 07/30/1987 | WO1987004351A1 Method for the diagnosis and treatment of inflammation |
| 07/30/1987 | WO1987004350A1 Process for improving the adherence of gels to mucous membranes |
| 07/30/1987 | WO1987004347A1 Solubilization of hydrophobic materials using lysophospholipid |
| 07/30/1987 | WO1987004346A1 Composition comprising an oxygenated cholesterol and use thereof for topical treatment of diseases |
| 07/30/1987 | WO1987004345A1 Topical antiinflammatory compositions |
| 07/30/1987 | WO1987003490A3 Transdermal delivery system |
| 07/30/1987 | DE3602434A1 Use of solid fatty acid glycerides as aids for reducing particle size and the use of size-reduced products for pharmaceutical formulations |
| 07/29/1987 | EP0230332A1 A pharmaceutical composition with sustained release of the active component and a process for the preparation thereof |
| 07/29/1987 | EP0230265A2 Stabilized viral antigen, process for its preparation and its use |
| 07/29/1987 | EP0230226A2 Antimycotic emulsions |
| 07/28/1987 | US4683299 Sugar esters and an improved anhydrous method of manufacture |
| 07/28/1987 | US4683131 Divisible pharmaceutical tablet with delayed active ingredient release |
| 07/28/1987 | CA1224776A1 Method for producing copoly(amino acids) |
| 07/28/1987 | CA1224718A1 Anti-cancer drugs comprising platinum complexes |
| 07/22/1987 | EP0229652A2 Stabilized tocopherol in dry, particulate, free-flowing form |
| 07/22/1987 | EP0229564A1 Glycoproteins modified by oxidation followed by reduction, which inhibit ribosomes, production process and immunotoxines containing such a glycoprotein |
| 07/22/1987 | EP0229400A2 Fatty acids modified polyesters, process for their preparation, and their use for the increase of viscosity in compositions containing tensides |
| 07/22/1987 | EP0229155A1 Pharmaceutical complex and composition to inhibit hair loss |
| 07/21/1987 | US4681876 Antifungal utility of bile acids |
| 07/21/1987 | US4681766 Sugar and sugarless coatings |
| 07/21/1987 | US4681759 Polyvinylpyrrolidone, antiulcer |
| 07/21/1987 | US4681635 Topical collodion compositions |
| 07/21/1987 | CA1224461A1 Antibiotic compound, a method for its preparation and compositions containing it |
| 07/16/1987 | WO1987004171A1 Process for preparing antibody complex |
| 07/16/1987 | WO1987004154A1 Melphalan derivatives |
| 07/16/1987 | DE3600777A1 Preservation process |
| 07/15/1987 | EP0229016A2 Interleukin-2 compositions |
| 07/15/1987 | EP0229000A2 Encapsulation composition for use with chewing gum and edible products |
| 07/15/1987 | EP0228999A2 Coatings for chewing gums containing gum arabic and a soluble calcium salt |
| 07/15/1987 | EP0228862A2 Stabilized human tissue plasminogen activator compositions |
| 07/15/1987 | CN86106889A Inclusion complex of 7-isopropoxy-isoflavon formed with cyclodextrin, the preparation thereof and pharmaceutical compositions containing these compounds as active ingredient |
| 07/14/1987 | US4680323 Method and composition for the preparation of controlled long-acting pharmaceuticals for oral administration |
| 07/14/1987 | US4680315 Powder mixture having high propylene glycol content and process for the preparation thereof |
| 07/14/1987 | US4680312 Stable prostaglandin E gels utilizing colloidal silicon dioxide as a gel-forming agent |
| 07/14/1987 | US4680175 Interferon administration vehicles |
| 07/14/1987 | CA1224150A1 Stable water-in-oil emulsions containing polyoxyalkylene block copolymers |
| 07/14/1987 | CA1224149A1 Clear analgesic gels with reduced tackiness |
| 07/14/1987 | CA1224147A1 Betamethasone dipropionate cream |
| 07/14/1987 | CA1224143A1 Increasing the enteral absorbability of heparin or heparinoids, and the heparin or heparinoid preparation thus obtainable |
| 07/14/1987 | CA1224142A1 Transfer factor composition and skin treatment |
| 07/08/1987 | EP0228243A1 Monoclonal antibodies having binding specificity to human prostate tumor-associated antigens and methods for employing the same |
| 07/08/1987 | EP0228223A2 Non-irritating suprofen solution |
| 07/08/1987 | EP0228164A2 Effervescent composition containing ibuprofen |
| 07/08/1987 | EP0227656A1 Pharmaceutical compositions containing gels |
| 07/08/1987 | CN86108096A Stabilized benzimidazole derivatives |
| 07/07/1987 | US4678814 Fluorescent and amgnetized derivative copolymers, medical applications |
| 07/07/1987 | US4678668 Method of reducing soft tissue swelling and pain |
| 07/07/1987 | US4678667 Diagnosis and therapy of tumors |
| 07/07/1987 | US4678666 Piroxicam |
| 07/07/1987 | US4678665 Polyanionic compounds derived from aromatic ethers of polyglycerols |
| 07/07/1987 | US4678664 Mineral oil gels |
| 07/07/1987 | US4678663 Hyperpigmentation |
| 07/07/1987 | US4678659 Capsules for oral administration |
| 07/07/1987 | US4678604 2-(1'-hydroxyimino-ethyl)-1,3,3,4,4-pentamethylcyclopentene and fragrance compositions containing same |
| 07/07/1987 | US4678516 Hydroxypropyl methyl cellulose |
| 07/07/1987 | CA1223831A1 Modified nucleotides, methods of preparing and utilizing and compositions containing the same |
| 07/07/1987 | CA1223819A1 Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one |
| 07/07/1987 | CA1223818A1 Penetrating topical pharmaceutical compositions containing n-(2-hydroxyethyl) pyrrolidone |
| 07/02/1987 | WO1987003891A1 Biodegradable synthetic polypeptide and its utilization in therapeutics |
| 07/01/1987 | EP0227603A2 Confectionery delivery system for actives |
| 07/01/1987 | EP0227531A2 Pyroglutamic acid esters used as dermal penetration enhancers for drugs |
| 07/01/1987 | EP0227494A1 Pharmaceutical composition of the type which undergoes liquid-gel phase transition |
| 07/01/1987 | EP0227400A2 Inhibition of post-surgical adhesion formation by the topical administration of tissue plasminogen activator |
| 07/01/1987 | EP0226671A1 Titanium dioxide suspension for use in film coating |
| 06/30/1987 | US4677131 Cyclic ureas as dermal penetration enhancers |
| 06/29/1987 | EP0163696A4 Use of a bioadhesive. |
| 06/24/1987 | EP0226419A2 Anti-human ovarian cancer immunotoxins and methods of use thereof |
| 06/24/1987 | EP0226418A2 Anti-human ovarian cancer immunotoxins and methods of use thereof |
| 06/24/1987 | CN85109101A Process for preparation of antibacterial unguent |
| 06/23/1987 | US4675422 Organometallic compounds |
| 06/23/1987 | US4675400 Bifunctional derivatives of 4-desacetyl indole-dihydroindole alkaloids |